Patient and phaRmacist telephonic encounters (PARTE) in an underserved rural patient population with asthma: Results of a pilot study

Telemedicine and e-Health

Volumn 18, Issue 6, 2012, Pages 427-433

  Young, Henry N ^a   Havican, S Nadra ^b   Griesbach, Sara ^c   Thorpe, Joshua M ^a   Chewning, Betty A ^a   Sorkness, Christine A ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b Family Health Center Pharmacy of Marshfield Inc   (United States)

^c MARSHFIELD CLINIC   (United States)

Author keywords

asthma; intervention; patient pharmacist communication; rural; telepharmacy; underserved

Indexed keywords

ASTHMA; ASTHMA CONTROL; CONTROL GROUPS; INTERVENTION; MEDICATION ADHERENCE; PATIENT POPULATION; PILOT STUDIES; QUALITATIVE INTERVIEWS; RURAL PATIENTS; SELF MANAGEMENT; TELEPHARMACY; UNDERSERVED;

DISEASES; RURAL AREAS;

PATIENT TREATMENT;

ANTIASTHMATIC AGENT;

ADULT; ARTICLE; ASTHMA; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEALTH CARE PLANNING; HEALTH STATUS INDICATOR; HUMAN; HUMAN RELATION; INSTRUMENTATION; MALE; METHODOLOGY; MIDDLE AGED; ORGANIZATION AND MANAGEMENT; PATIENT CARE; PATIENT COMPLIANCE; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL; RURAL POPULATION; SELF CARE; STATISTICS; TELEMEDICINE; TELEPHONE; UNITED STATES;

ADULT; ANTI-ASTHMATIC AGENTS; ASTHMA; CONFIDENCE INTERVALS; FEMALE; HEALTH STATUS INDICATORS; HUMANS; MALE; MEDICALLY UNDERSERVED AREA; MEDICATION ADHERENCE; MIDDLE AGED; PATIENT CARE; PILOT PROJECTS; PROFESSIONAL-PATIENT RELATIONS; RURAL POPULATION; SELF CARE; TELEMEDICINE; TELEPHONE; WISCONSIN;

EID: 84864229548     PISSN: 15305627     EISSN: 15563669     Source Type: Journal    
DOI: 10.1089/tmj.2011.0194     Document Type: Article

References (45)

1. Akinbami U, Moorman JE, Liu X. Asthma prevalence, healthcare use, ano mortality: United States, 2005-2009. Natl Health Stat Report 2011;(32): 1-14.
2. Jackson JE, Doescher MP, Hart LG. A national study of lifetime asthma orevalence and trends in metro and non-metro counties, 2000-2003. 2007 Available at http://depts.washington.edu/uwrhrc/uploads/RHRC-WP108-Jackson.pdf (last accessed September 14, 2010).
3. American Lung Association. Trends in asthma morbidity and mortality. Available at www.lungusa.org/finding-cures/our-research/trend-reports/asthma- trend-reportpdf (last accessed April 7, 2011).
4. Mehuys E, Van Bortel L, De Bolle L, Van Tongelen I, Annemans L, Remon JP, Brusselle G. Effectiveness of pharmacist intervention for asthma contra improvement. Eur Respir J 2008;31 790-799.
5. Gillisen A. Patient's adherence in asthma. J Physiol Pharmacol 2007;58(Supp 5):205-222.
6. Smith JR, Mildenhall S, Noble M, Mugford M, Shepstone L, Harrison BD. Clinician-assessed poor compliance identifies adults with severe asthma who are at risk of adverse outcomes. J Asthma 2005;42:437-445.
7. Bender BG. Overcoming barriers to nonadherence in asthma treatment. J Allergy Clin Immunol 2002;109(6 Suppl):S554-S559.
8. Howell G. Nonadherence to medical therapy in asthma: Risk factors, barriers, and strategies for improving. J Asthma 2008;45:723-729.
9. Hibbard JH, Stockard J, Mahoney ER, Tusler M. Development of the Patient Activation Measure (PAM): Conceptualizing and measuring activation in oatients and consumers. Health Serv Res 2004;39:1005-1026.
10. Herborg H, Soendergaard B, Froekjaer B, Fonnesbaek L, Jorgensen T, Hepler CD, Grainger-Rousseau TJ, Ersboell BK. Improving drug therapy for patients with asthma-Part 1: Patient outcomes. J Am Pharm Assoc (Wash) 2001;41: 539-550.
11. Herborg H, Soendergaard B, Jorgensen T, Fonnesbaek L, Hepler CD, Holst H Froekjaer B. Improving drug therapy for patients with asthma-Part 2: Use of antiasthma medications. J Am Pharm Assoc (Wash) 2001;41:551 -559.
12. Mangiapane S, Schulz M, Muhlig S, I hie P, Schubert I, Waldmann HC. Community pharmacy-based pharmaceutical care for asthma patients. Ann Pharmacother 2005;39:1817-1822.
13. Valet RS, Perry TT, HartertTV. Rural health disparities in asthma care ano outcomes. J Allergy Clin Immunol 2009;123:1220-1225
14. Ownby DR. Asthma in rural America. Ann Allergy Asthma Immunol 2005;95 (5 Suppl 1):S17-S22.
15. Withy K, Davis J. Followup after an emergency department visit for asthma: Urban/rural patterns. Ethn D/s 2008;18(2 Suppl 2):S2-247-S2-251
16. Bender BG, Apter A, Bogen DK, Dickinson P, Fisher L, Wamboldt FS, Westfall JM. Test of an interactive voice response intervention to improve adherence to controller medications in adults with asthma. J Am Board Fam Med 2010;23:159-165
17. Angaran DM. Telemedicine and telepharmacy: Current status and future implications. Am J Health Syst Pharm 1999;56:1405-1426.
18. McLean S, Chandler D, Nurmatov U, Liu J, Pagliari C, Car J, Sheikh A. Telehealthcare for asthma. Cochrane Database Syst Rev 2O1O;(10):CD007717.
19. Poulson LK, Nissen L, Coombes I. Pharmaceutical review using telemedicine-A before and after feasibility study. J Telemed Telecare 2010;16:95-99.
20. Elliott RA, Barber N, Clifford S, Home R, Hartley E. The cost effectiveness of a telephone-based pharmacy advisory service to improve adherence to newly orescribed medicines. Pharm World Sei 2008;30:17-23.
21. Clifton GD, Byer H, Heaton K, Haberman DJ, Gill H. Provision of pharmacy services to underserved populations via remote dispensing and two-way videoconferencing. Am J Health Syst Pharm 2003;60:2577-2582.
22. Barbanel D, Eldridge S, Griffiths C. Can a self-management programme delivered by a community pharmacist improve asthma control? A randomiseo trial. Thorax 2003;58:851-854.
23. Bynum A, Hopkins D, Thomas A, Copeland N, Irwin C. The effect of telepharmacy counseling on metered-dose inhaler technique among adolescents with asthma in rural Arkansas. Telemed J E Health 2001;7:207-217.
24. Young HN, Havican SN, Chewning BA, Sorkness CA, Ruppel X, Griesbach SA. Patient And phaRmacist Telephonic Encounters (PARTE) in an underserved rura oopulation with asthma: Methods and rationale. Innov Pharm 2011;2:1-10
25. Gardner M, Boyce RW, Herrier RN. Pharmacist-patient consultation program PPCP-Unit I. Washington, DC: Indian Health Service, U.S. Public Health Service, 1997.
26. Weiss M, Britten N. What is concordance? Pharmaceut J 2003;271:493.
27. Nelson P, Young HN, Knobloch MJ, Griesbach SA. Telephonic monitoring ano optimization of inhaler technique. Telemed J E Health 2011;17:734-740
28. Bandura A. Self-efficacy: The exercise of control. New York: Freeman, 1997
29. Bird L, Arthur A, Cox K. "Did the trial kill the intervention?" Experiences from the development, implementation and evaluation of a complex intervention. BMC Med Res Methodol 2011;11:24.
30. Murtagh MJ, Thomson RG, May CR, RapleyT, Heaven BR, Graham RH, Kaner EF, Stobbart L, Eccles MP. Qualitative methods in a randomised controlled trial:The role of an integrated qualitative process evaluation in providing evidence to discontinue the intervention in one arm of a trial of a decision support tool. Qual Saf Health Care 2007;16:224-229.
31. Nathan RA, Sorkness CA, Kosinski M, Schatz M, Li JT, Marcus P, Murray JJ, Pendergraft TB. Development of the Asthma Control Test: A survey for assessing asthma control. J Allergy Clin Immunol 2004;113:59-65.
32. Schatz M, Sorkness CA, Li JT, Marcus P, Murray JJ, Nathan RA, Kosinski M, Pendergraft TB, Jhingran P. Asthma control test: Reliability, validity, ano responsiveness in patients not previously followed by asthma specialists. J Allergy Clin Immunol 2006;117:549-556.
33. Hibbard JH, Mahoney ER, Stockard J, Tusler M. Development and testing of a short form of the patient activation measure. Health Serv Res 2005;40:1918-1930
34. Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich) 2008;10:348-354.
35. Barber JA, Thompson SG. Analysis of cost data in randomized trials: An application of the non-parametric bootstrap. Stat Med 2000;19:3219-3236.
36. Efron B, Tibshirani RJ. An introduction to the bootstrap. New York: Chapman & Hall, 1993.
37. Stata statistical software: Release 11. College Station, TX: StataCorp LP, 2009.
38. Bender BG, Rankin A Tran ZV, Wamboldt FS. Brief-interval telephone surveys of medication adherence and asthma symptoms in the Childhood Asthma Management Program Continuation Study. Ann Allergy Asthma Immunol 2008;101:382-386.
39. Hibbard JH, Mahoney ER, Stock R, Tusler M. Do increases in patient activation result in improved self-management behaviors? Health Serv Res 2007;42:1443-1463.
40. van der Meer V, van Stel HF, Bakker MJ, Roldaan AC, Assendelft WJ, Sterk PJ, Rabe KF, Sont JK. Weekly self-monitoring and treatment adjustment benefit oatients with partly controlled and uncontrolled asthma: An analysis of the SMASHING study. Respir Res 2010:11:74.
41. Expert Panel Report 3 (EPR-3): Guidelines for the diagnosis and management of asthma-Summary report 2007. J Allergy Clin Immunol 2OO7;120(5 Suppl):S94-S138. Erratum in J Allergy Clin Immunol 2008;121:1330.
42. Rothkopf J, Brookler K, Wadhwa S, Sajovetz M. Medicaid patients seen at federally qualified health centers use hospital services less than those seen by orivate providers. Health Aff 2011;30:1335-1342.
43. Probst JC, Laditka JN, Laditka SB. Association between community health center and rural health clinic presence and county-level hospitalization rates for ambulatory care sensitive conditions: An analysis across eight US states. BMC Health Serv Res 2009;9:134.
44. Zhang W, Mueller KJ, Chen LW, Conway K. The role of rural health clinics in nospitalization due to ambulatory care sensitive conditions: A study in Nebraska. J Rural Health 2006;22:220-223.
45. Rust G, Baltrus P, Ye JL, Daniels E, Quarshie A, Boumbulian P, Strothers H. Presence of a community health center and uninsured emergency department visit rates in rural counties. J Rural Health 2009;25:8-16.